18 November 2009
Notification of major interest in shares
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: | Futura Medical plc |
| 2. Reason for the notification | |
| An acquisition or disposal of voting rights | Yes |
| 3. Full name of person(s) subject to the notification obligation: | Brookwell Limited |
| 4. Full name of shareholder(s) (if different from 3.): | Nortrust Nominees Limited |
| 5. Date of the transaction and date on which the threshold is crossed or reached: | 18 November 2009 |
| 6. Date on which issuer notified: | 18 November 2009 |
| 7. Threshold(s) that is/are crossed or reached: | 5% |
| 8. Notified details: |
|
| A: Voting rights attached to shares | |||||||
| Class/type of shares if possible using the ISIN CODE |
Situation previous to the Triggering transaction | Resulting situation after the triggering transaction | |||||
| Number of Shares | Number of Voting Rights | Number of shares Direct | Number of voting rights | % of voting rights | |||
| Direct | Indirect | Direct | Indirect | ||||
| Ordinary Shares GB0033278473 |
3,233,835 | 3,233,835 | 3,233,835 | 4.79% | 4.79% | ||
| B: Financial Instruments | ||||
| Resulting situation after the triggering transaction | ||||
| Type of financial instrument | Expiration date | Exercise/ Conversion Period/ Date | Number of voting rights that may be acquired if the instrument is exercised/ converted | % of voting rights |
| None | ||||
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | ||||
| Resulting situation after the triggering transaction | ||||
| Type of financial instrument |
Exercise price | Expiration date | Number of voting rights instrument refers to | % of voting rights |
| None | ||||
| Total (A+B+C) | |
| Number of voting rights | % of voting rights |
| 3,233,835 |
4.79% |
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: |
| None |
| Proxy Voting: | |
| 10. Name of the proxy holder: | N/A |
| 11. Number of voting rights proxy holder will cease to hold: | N/A |
| 12. Date on which proxy holder will cease to hold voting rights: | N/A |
| 13. Additional information: | Progressive AIM Realisation Limited is Investment Manager to Brookwell Limited |
| 14. Contact name: | Russell Scott |
| 15. Contact telephone number: | 020 7490 4355 |
For further information please contact:
Futura Medical plc
James Barder, Chief Executive
Tel: +44 (0) 1483 685 670
james.barder@futuramedical.com
www.futuramedical.com
Nominated Adviser:
Nomura Code Securities Limited
Phil Walker / Giles Balleny
Tel: +44 (0) 20 7776 1200
For media enquiries please contact:
Buchanan Communications Limited
Mark Court / Stasa Filiplic / George Prassas
Tel: +44 (0) 20 7466 5000
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.